Opioid antagonism enhances marijuana's effects in heavy marijuana smokers

Psychopharmacology

Volumn 211, Issue 2, 2010, Pages 141-148

  Cooper, Ziva D ^a   Haney, Margaret ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Cannabinoid; Marijuana; Naltrexone; Opioid; Opioid receptor; THC

Indexed keywords

CANNABIS; NALTREXONE; PLACEBO; DRONABINOL; NARCOTIC ANTAGONIST;

ADULT; ARTICLE; CANNABIS ADDICTION; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CANNABIS SMOKING; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HEART RATE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; NALTREXONE; NARCOTIC ANTAGONISTS; PSYCHOMOTOR PERFORMANCE; TETRAHYDROCANNABINOL; DRONABINOL;

EID: 77955469620     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1875-y     Document Type: Article

References (30)

1. PM Beardsley RL Balster LS Harris 1986 Dependence on tetrahydrocannabinol in rhesus monkeys J Pharmacol Exp Ther 239 311 319 1:CAS:528: DyaL2sXht1yqsg%3D%3D 3021952
2. D Braida M Pozzi R Cavallini M Sala 2001 Conditioned place preference induced by the cannabinoid agonist CP 55, 940: interaction with the opioid system Neuroscience 104 923 926 10.1016/S0306-4522(01)00210-X 1:CAS:528:DC%2BD3MXlt1Sitro%3D 11457579 (Pubitemid 32701955)
3. D Braida S Iosuè S Pegorini M Sala 2004 Delta9- tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats Eur J Pharmacol 506 63 69 10.1016/j.ejphar.2004.10.043 1:CAS:528:DC%2BD2cXhtVaqtrnP 15588625 (Pubitemid 39575086)
4. L Fattore G Cossu CM Martellotta W Fratta 2001 Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55, 212-2 in rats Psychopharmacology 156 410 416 10.1007/s002130100734 1:CAS:528: DC%2BD3MXmvVygtb8%3D 11498718 (Pubitemid 32695850)
5. RW Foltin JV Brady MW Fischman CS Emurian J Dominitz 1987 Effects of smoked marijuana on social interaction in small groups Drug Alcohol Depend 20 87 93 10.1016/0376-8716(87)90079-2 1:STN:280:DyaL1c%2FlsVGlug%3D%3D 3678046
6. RW Foltin MW Fischman PA Pippen TH Kelly 1993 Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans Drug Alcohol Depend 32 93 106 10.1016/0376-8716(93)80001-U 1:CAS:528: DyaK3sXltlWnsbY%3D 8508730
7. MK Greenwald ML Stitzer 2000 Antinociceptive, subjective and behavioral effects of smoked marijuana in humans Drug Alcohol Depend 59 261 275 10.1016/S0376-8716(99)00128-3 1:CAS:528:DC%2BD3cXjt1ejsbk%3D 10812286 (Pubitemid 30254241)
8. M Haney 2007 Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers Neuropsychopharmacology 32 1391 1403 10.1038/sj.npp.1301243 1:CAS:528:DC%2BD2sXltlaqtLs%3D 17091128 (Pubitemid 46788849)
9. M Haney SD Comer AS Ward RW Foltin MW Fischman 1997 Factors influencing marijuana self-administration by humans Behav Pharmacol 8 101 112 10.1097/00008877-199702000-00009 1:CAS:528:DyaK2sXltlKisLs%3D 9833006
10. M Haney AS Ward SD Comer RW Foltin MW Fischman 1999 Abstinence symptoms following smoked marijuana in humans Psychopharmacology 141 395 404 10.1007/s002130050849 1:CAS:528:DyaK1MXhtlyitbY%3D 10090647 (Pubitemid 29190008)
11. M Haney A Bisaga RW Foltin 2003 Interaction between naltrexone and oral THC in heavy marijuana smokers Psychopharmacology 166 77 85 1:CAS:528: DC%2BD3sXhtFKlsbk%3D 12491025
12. CL Hart WG van Gorp M Haney RW Foltin MW Fischman 2001 Effects of acute smoked marijuana on complex cognitive performance Neuropsychopharmacology 29 158 170
13. ID Hirschhorn JA Rosecrans 1974 Morphine and delta 9- tetrahydrocannabinol: tolerance to the stimulus effects Psychopharmacologia 36 243 253 10.1007/BF00421806 1:CAS:528:DyaE2MXkslWlsb0%3D 4858714
14. MA Huestis SJ Boyd SJ Heischman KL Preston D Bonnet G Le Fur DA Gorelick 2007 Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users Psychopharmacology 194 505 515 10.1007/s00213-007-0861-5 1:CAS:528:DC%2BD2sXhtVynur7E 17619859 (Pubitemid 47492992)
15. 9-THC and (R)-methanandamide in rats Psychopharmacology 184 36 45 10.1007/s00213-005-0225-y 16307294 (Pubitemid 43005755)
16. Z Justinova G Tanda P Munzar SR Goldberg 2004 The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys Psychopharmacology 173 186 194 10.1007/s00213-003-1693-6 1:CAS:528:DC%2BD2cXivFSrtr4%3D 14668977 (Pubitemid 38591164)
17. Z Justinova P Munzar LV Panlilio S Yasar GH Redhi G Tanda SR Goldberg 2008 Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant Neuropsychopharmacology 33 2870 2877 10.1038/npp.2008.21 1:CAS:528:DC%2BD1cXht1Cms7bI 18305459
18. S Kaymakçalan IH Ayhan FC Tulunay 1977 Naloxone-induced or postwithdrawal abstinence signs in delta 9-tetrahydrocannabinol-tolerant rats Psychopharmacology 55 243 249 10.1007/BF00497855 414285
19. JX Li LR McMahon LR Gerak GL Becker CP France 2008 Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception Psychopharmacology 199 199 208 10.1007/s00213-008-1157-0 1:CAS:528:DC%2BD1cXotV2ntbY%3D 18470505
20. JA Lile TH Kelly DJ Pinsky LR Hays 2009 Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol Psychopharmacology 203 241 250 10.1007/s00213-008-1393-3 1:CAS:528:DC%2BD1cXhtl2lsb7I 19018520
21. M Navarro J Chowen A Rocío M Carrera I del Arco MA Villanúa Y Martin AJ Roberts GF Koob FR de Fonseca 1998 CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats Neuroreport 9 3397 402 10.1097/00001756-199810260-00012 1:CAS:528:DyaK1cXotV2kt7o%3D 9855288
22. M Navarro MR Carrera W Fratta O Valverde G Cossu L Fattore JA Chowen R Gomez I del Arco MA Villanua R Maldonado GF Koob F Rodriguez de Fonseca 2001 Functional interaction between opioid and cannabinoid receptors in drug self-administration J Neurosci 21 5344 5350 1:CAS:528:DC%2BD3MXkvFSrsLk%3D 11438610
23. P Robledo F Berrendero A Ozaita R Maldonado 2008 Advances in the field of cannabinoid-opioid cross-talk Addict Biol 13 213 224 10.1111/j.1369-1600.2008. 00107.x 1:CAS:528:DC%2BD1cXnvVOksLg%3D 18482431 (Pubitemid 351692983)
24. M Solinas SR Goldberg 2005 Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems Neuropsychopharmacology 11 2035 2045 10.1038/sj.npp.1300720 (Pubitemid 43093503)
25. M Solinas A Zangen N Thirlet SR Goldberg 2004 Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9 tetrahydrocannabinol Eur J Neurosci 19 3183 3192 10.1111/j.0953-816X.2004.03420. x 1:STN:280:DC%2BD2czhs1aluw%3D%3D 15217374 (Pubitemid 38859535)
26. MS Spano L Fattore G Cossu S Deiana P Fadda W Fratta 2004 CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat Br J Pharmacol 143 343 350 10.1038/sj.bjp.0705932 1:CAS:528: DC%2BD2cXptVyis7k%3D 15339858 (Pubitemid 39424822)
27. S Vlachou GG Nomikos G Panagis 2005 CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat Psychopharmacology 179 498 508 10.1007/s00213-004-2050-0 1:CAS:528:DC%2BD2MXjtV2iurk%3D 15821959 (Pubitemid 40569051)
28. SR Wachtel H de Wit 2000 Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans Drug Alcohol Depend 59 251 260 10.1016/S0376-8716(99)00127-1 1:CAS:528:DC%2BD3cXjt1ejsbg%3D 10812285 (Pubitemid 30254240)
29. ME Wall DR Brine M Perez-Reyes 1981 Metabolism and disposition of naltrexone in man after oral and intravenous administration Drug Metab Dispos 9 369 375 1:CAS:528:DyaL3MXlt1Grs78%3D 6114837
30. A Zangen M Solinas S Ikemoto SR Goldberg RA Wise 2006 Two brain sites for cannabinoid reward J Neurosci 26 4901 4907 10.1523/JNEUROSCI.3554-05.2006 1:CAS:528:DC%2BD28XkvFSgtbo%3D 16672664 (Pubitemid 44315331)